综合性失眠和睡眠呼吸暂停的全科医生管理
Alexander Sweetman1, Oliver Frank2, Nigel Stocks3
1PhD, Research Associate, Adelaide Institute for Sleep Health (AISH): A Centre of Research Excellence, College of Medicine and Public Health, Flinders University, SA; Research Associate, National Centre for Sleep Health Services Research (NCSHSR): An NHMRC Centre of Research Excellence, Flinders University, SA.
Australian journal of general practice
|September 4, 2023
概括
失眠和阻塞性睡眠呼吸暂停往往并存,使患者的健康状况恶化. 一般医生应该对这两种情况进行查,并提供综合治疗,如认知行为疗法和CPAP疗法.
科学领域:
- 睡眠医学 睡眠医学
- 一般实践一般实践
背景情况:
- 失眠和阻塞性睡眠呼吸暂停是常见的睡眠障碍,经常同时发生.
- 伴随性失眠和睡眠呼吸暂停导致白天功能,心理健康和身体健康状况较差.
- 一般医生在评估和管理这种普遍疾病时遇到不同的挑战.
研究的目的:
- 概述澳大利亚一般医院的共病性失眠和睡眠呼吸暂停的患病率,后果,评估和管理.
主要方法:
- 文献综述和综合当前的证据和指导方针.
主要成果:
- 患有任何一种疾病的患者应接受另一种疾病的查.
- 综合治疗方法对于并发病例是必要的.
结论:
- 建议用于失眠的认知行为疗法.
- 生活方式/体重管理和持续正气道压力 (CPAP) 治疗是适度至严重阻塞性睡眠呼吸暂停的第一线治疗方法.
更多相关视频
相关概念视频
Sleep Apnea
184
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
184
Management of Insomnia
278
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
278
Insomnia
106
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
106
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
CNS Depressants: Barbiturates and Benzodiazepines
314
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
314
Sedatives and Hypnotics Drugs: Miscellaneous Agents
200
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
200


